NEW ELASTIN INFUSION THERAPY USES MICROCURRENT TO ENHANCE DELIVERY

TBI, Inc. of Colleyville, Texas, announced an agreement with Nulastin, Inc. to provide a new biotechnological skincare program using as its main ingredient genetically engineered Human Tropoelastin and enhancing it’s delivery and incorporation into skin with Iontophoresis using TBI’s MCR microcurrent units. Tropoelastin is the soluble precursor to the human matrix protein, Elastin. Elastin is the second most abundant protein in the skin and the one that gives the skin its resiliency. In humans native Elastin production is inhibited or curtailed after the onset of puberty. Thereafter Elastin is gradually lost ultimately causing the appearance of aged skin.

Nulastin was founded in 2004 to market and develop genomic-based biopolymers based on the research of Dr. Bruce Ensley. Dr Ensley a PH.D in microbiology holds seventeen patents relating to human matrix proteins and is an often published author. “The human skin protein Elastin is expensive and difficult to produce, it has never been used as personal care ingredients because of the delivery and production challenges,” said Ensley. 

However, Tropoelastin is the precursor to Elastin that penetrates the outer layers of skin and replenishes lost Elastin. Using sophisticated genetic engineering techniques. Dr. Ensley synthesized the gene for, human Tropoelastin gene and introduced it into micro-organisms that then make the Tropelastin. The resulting protein is identical to human. Tropoelastin and is functional in skin where it naturally interact with other enzymes to become part of the skin.

The Elastin Infusion Therapy is an in-office, non-invasive, thirty minute treatment using proprietary Tropoelastin products and applied using Chiro950™ micro current wands. It is estimated that one treatment can replace as much as tow years of lost Elastin.

In addition, patient home therapy maintenance includes Dermalastyl products that contain Tropoelastin and proprietary peptides to both stimulate collagen synthesis and replenish Elastin. No other skin car product contains a biotechnology-based, human protein that functions in the skin.

A recent clinical study under the direction of NYU’s Dr. Stephen Lamm included 35 subjects done using sophisticated laser photography show significant results from the use of Dermalastyl products in as little as 6 weeks. Most participants reported a youthful glow on the face, better hydration lasing all day, positive skin texture changes, and firmer skin with fewer visible lines.

The Iontophoroesis lastin Infusion Therapy is a painless procedure estimated to return up to 2 years in lost elastin during each treatment.